Low expression of FCGR3B is also observed in the large majority of AML cell lines, suggesting that its transcriptional off-state is robustly maintained in cell culture—much as the CD33 on-state is maintained (Figure 1D). Here, FCGR3B is linked to acute myeloid leukemia.